M&A Deal Summary

Bausch & Lomb Acquires Elios Vision

On December 11, 2024, Bausch & Lomb acquired medical products company Elios Vision

Acquisition Highlights
  • This is Bausch & Lomb’s 6th transaction in the Medical Products sector.
  • This is Bausch & Lomb’s 5th transaction in the United States.
  • This is Bausch & Lomb’s 3rd transaction in California.

M&A Deal Summary
Date 2024-12-11
Target Elios Vision
Sector Medical Products
Buyer(s) Bausch & Lomb
Deal Type Add-on Acquisition
Advisor(s) Leerink Partners (Financial)
Wilson Sonsini Goodrich & Rosati (Legal)

Target

Elios Vision

Los Angeles, California, United States
Elios Vision is a developer of the ELIOS™ procedure, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser. Elios Vision was founded in 2019 and is based in Los Angeles, California.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bausch & Lomb

Rochester, New York, United States
Category Company
Founded 1853
Sector Medical Products
Revenue 3.3B USD (2013)
DESCRIPTION

Bausch & Lomb is a manufacturer of ophthalmic products.

DEAL STATS #
Overall 8 of 8
Sector (Medical Products) 6 of 6
Type (Add-on Acquisition) 6 of 6
State (California) 3 of 3
Country (United States) 5 of 5
Year (2024) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-23 Trukera Medical

Southlake, Texas, United States

Trukera Medical develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve the standard of care by objectively testing for disease biomarkers in tears at the point-of-care. Trukera Medical is based in Southlake, Texas.

Buy -
Mergr

Product

Company

Legal